ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

CUSIP: 29664WAB1

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Debt / NOTE 4.000%11/1
Market price (% of par)
40.06%
Total 13F principal
$236,594,851
Principal change
-$2,797,313
Total reported market value
$103,500,121
Number of holders
20
Value change
-$397,411
Number of buys
10
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 29664WAB1?
CUSIP 29664WAB1 identifies 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q1 2023

As of 31 Mar 2023, ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 was held by 20 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $236,594,851 in principal (par value) of the bond. The largest 10 bondholders included Pentwater Capital Management LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., DAVIDSON KEMPNER CAPITAL MANAGEMENT LP, DAVIDSON KEMPNER PARTNERS, WHITEBOX ADVISORS LLC, AMERIPRISE FINANCIAL INC, AGF MANAGEMENT LTD, Affinity Asset Advisors, LLC, and SILVERBACK ASSET MANAGEMENT LLC. This page lists 20 institutional bondholders reporting positions for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.